Ovarian Cancer Clinical Trials
Find clinical trials for ovarian cancer. Search for ovarian cancer clinical trials in different cities and states across the United States.
FRαDCsFolate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients with Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
Sponsor:
Mayo Clinic
Location:
Code:
NCT06639074
Conditions
Advanced Fallopian Tube Carcinoma
Advanced Fallopian Tube High Grade Serous Adenocarcinoma
Advanced Ovarian Carcinoma
Advanced Ovarian Carcinosarcoma
Advanced Ovarian Clear Cell Adenocarcinoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biopsy
Biospecimen Collection
Computed Tomography
Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
Leukapheresis
NX-1607A Study of NX-1607 in Adults With Advanced Malignancies
Sponsor:
Nurix Therapeutics, Inc.
Location:
Code:
NCT05107674
Conditions
Ovarian Cancer, Epithelial
Gastric Cancer
GastroEsophageal Junction (GEJ) Cancer
Head and Neck Squamous Cell Carcinoma
Metastatic or Unresectable Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
NX-1607
Paclitaxel
Precision OncologySYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Sponsor:
Massive Bio, Inc.
Location:
Code:
NCT03452774
Conditions
Cancer, Metastatic
Cancer
Cancer of Pancreas
Cancer of Liver
Cancer of Stomach
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Clinical Trial Matching
ATX-295First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Sponsor:
Accent Therapeutics
Location:
Code:
NCT06799065
Conditions
Advanced Solid Tumors
Breast Cancer Recurrent
Ovarian Cancer
High-grade Serous Ovarian Carcinoma
Triple Negative Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ATX-295
AOH1996AOH1996 for the Treatment of Refractory Solid Tumors
Sponsor:
City of Hope Medical Center
Location:
Code:
NCT05227326
Conditions
Refractory Malignant Solid Neoplasm
Osteosarcoma
Leiomyosarcomas
Synovial Sarcomas
Ovarian Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PCNA Inhibitor AOH1996
COTI-2Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies
Sponsor:
Critical Outcome Technologies Inc.
Location:
Code:
NCT02433626
Conditions
Ovarian Cancer
Fallopian Tube Cancer
Endometrial Cancer
Cervical Cancer
Peritoneal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
COTI2
Cisplatin
PrehabilitationPrehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
Sponsor:
Mayo Clinic
Location:
Code:
NCT05047926
Conditions
Advanced Ovarian Carcinoma
Stage IIIC Fallopian Tube Cancer AJCC V8
Stage IIIC Ovarian Cancer AJCC V8
Stage IIIC Primary Peritoneal Cancer AJCC V8
Stage IV Fallopian Tube Cancer AJCC V8
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Behavioral Counseling
Nutritional Supplement Drink
Physical Activity
Survey Administration
Computed Tomography
REGN5668, Cemiplimab & REGN4018A Trial to Find Out How Safe REGN5668 is and How Well it Works When Given With Either Cemiplimab or REGN4018
Sponsor:
Regeneron Pharmaceuticals
Location:
Code:
NCT04590326
Conditions
Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Endometrial Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
REGN5668
Cemiplimab
REGN4018
Sarilumab
Alternate Day FastingAlternate Day Fasting After Surgery for Patients Undergoing Chemotherapy
Sponsor:
Northwestern University
Location:
Code:
NCT05990426
Conditions
Ovary Cancer
Endometrial Cancer
Uterine Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FAST Intervention
Ovarian-Sparing RadiotherapyOvarian-Sparing Adaptive Radiotherapy in Young Adult Women
Sponsor:
Washington University School of Medicine
Location:
Code:
NCT06904365
Conditions
Uterine Cancer
Rectal Cancer
Colon Cancer
Breast Cancer
Lung Cancer
Eligibility Criteria
Sex: Female
Age: 18 - 50
Healthy Volunteers: Not accepted
Interventions
HyperSight cone beam computed tomography (CBCT) scan
ETHOS 2.0